Our study revealed that IL-27 stimulation in CLL patients results in a significant overall increase in TIM-3 expression within the lymphocyte population, primarily driven by statistically significant upregulation on CD8+ T cells. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.